Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Glibenclamide

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 84Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enforcement Report - Week of January 29, 2025
    Enforcement Report - Week of January 29, 2025

    29 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-29-2025-5490.pdf

    FDA
    29 Jan 2025
    Share Share
    Eton Pharmaceuticals Acquires U.S. Rights to Amglidia Suspension
    Eton Pharmaceuticals Acquires U.S. Rights to Amglidia Suspension

    25 Nov 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/11/25/2986515/0/en/Eton-Pharmaceuticals-Announces-Acquisition-of-U-S-Rights-to-Amglidia-Glyburide-Oral-Suspension.html

    GLOBENEWSWIRE
    25 Nov 2024
    Share Share
    Remedy Pharmaceuticals' Phase 3 Stroke Trial Shows Significant Effect
    Remedy Pharmaceuticals' Phase 3 Stroke Trial Shows Significant Effect

    01 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/remedy-pharmaceuticals-phase-3-trial-in-large-lesion-stroke-patients-demonstrates-statistically-significant-effect-at-one-year-302260511.html

    PR NEWSWIRE
    01 Oct 2024
    Share Share
    Remedy Gets Acute Stroke Drug Back Shows Positive Subgroup Analysis
    Remedy Gets Acute Stroke Drug Back Shows Positive Subgroup Analysis

    30 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/remedy-pharmaceuticals-gets-rights-to-acute-stroke-drug-back-from-biogen-announces-clinically-meaningful-and-statistically-significant-results-from-pre-specified-subgroup-and-post-hoc-analyses-of-phase-3-study-302157095.html

    PR NEWSWIRE
    30 May 2024
    Share Share
    SugarMDs LLC Issues Voluntary Nationwide Recall of Advanced Glucose Support Supplements Capsules Due to Presence of Undeclared Glyburide and Metformin
    SugarMDs LLC Issues Voluntary Nationwide Recall of Advanced Glucose Support Supplements Capsules Due to Presence of Undeclared Glyburide and Metformin

    15 Nov 2023

    // FDA

    https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/sugarmds-llc-issues-voluntary-nationwide-recall-advanced-glucose-support-supplements-capsules-due

    FDA
    15 Nov 2023
    Share Share
    Generic Drugmaker Admits to Price Fixing
    Generic Drugmaker Admits to Price Fixing

    01 Jun 2019

    // Zachary Brennan RAPS

    https://www.raps.org/news-and-articles/news-articles/2019/5/generic-drugmaker-admits-to-price-fixing

    Zachary Brennan RAPS
    01 Jun 2019
    Share Share